# PET/CT (Positron Emission Tomography / Computed Tomography) Investigations With BAY86-9596 (18F) (300 MBq) Following Single Intravenous Administration in Patients With Cancer or Inflammations.

> **NCT01297088** · PHASE1 · COMPLETED · sponsor: **Life Molecular Imaging SA** · enrollment: 24 (actual)

## Conditions studied

- Diagnostic Imaging

## Interventions

- **DRUG:** BAY86-9596

## Key facts

- **NCT ID:** NCT01297088
- **Lead sponsor:** Life Molecular Imaging SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-05
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2013-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01297088

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01297088, "PET/CT (Positron Emission Tomography / Computed Tomography) Investigations With BAY86-9596 (18F) (300 MBq) Following Single Intravenous Administration in Patients With Cancer or Inflammations.". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01297088. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*